Review



p c jun ser243 antibody  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc p c jun ser243 antibody
    ULK2 modulated c-Jun phosphorylation in ovarian cancer organoids. (A) Immunoblot analysis of phospho-c-Jun <t>(Ser243)</t> and c-Jun expression, with β-actin as loading control. (B) In vitro kinase assay to test the phosphorylation of c-Jun protein by ULK2 protein. (C-D) Quantification of ULK2 and c-Jun immunofluorescence signals was performed using IPP 6.0 software. E. ULK2 and c-Jun were examined by immunofluorescence. (F) Co-IP analysis indicated an interaction between ULK2 and c-Jun in chemoresistant ovarian cancer organoid. (G) Analysis of protein stability by cycloheximide (CHX) chase assay. Western blot of organoid lysates following treatment with CHX (50 μg/mL) for the indicated durations. (H) c-Jun was immunoprecipitated from chemoresistant ovarian cancer organoids and subsequently probed with an antiubiquitin antibody by Western blot. (I) Analysis of c-Jun mRNA expression by qRT-PCR. (J) c-Jun silencing reduced the cell viability of chemo-resistant ovarian cancer organoid. Organoids were treated with 8 μg/L cisplatin in different time intervals. (K) Assessment of glucose uptake following the knockdown of c-Jun. (L) Analysis of lactate production subsequent to c-Jun silencing. (M) Effect of c-Jun overexpression was verified by qRT-PCR. (N) The overexpression of c-Jun counteracted the decrease in cell viability caused by the upregulation of ULK2 in chemo-resistant ovarian cancer organoid. (O) Glucose uptake assay. (P) Effects of ULK2 overexpression and c-Jun S243A mutation on cell viability in chemoresistant ovarian cancer organoids. Organoids were treated with 8 μg/L cisplatin in different time intervals. Q. ULK2 overexpression suppresses glucose uptake, which is rescued by the c-Jun S243A mutation in chemoresistant ovarian cancer organoids. * p < .05; ** p < .01.
    P C Jun Ser243 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 30 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p+c+jun+ser243+antibody/Phospho-c-Jun+(Ser243)+Antibody/pmc12924953-50-0-17
    Average 94 stars, based on 30 article reviews
    p c jun ser243 antibody - by Bioz Stars, 2026-09
    94/100 stars

    Images

    1) Product Images from "ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation"

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation

    Journal: Science Progress

    doi: 10.1177/00368504261421695

    ULK2 modulated c-Jun phosphorylation in ovarian cancer organoids. (A) Immunoblot analysis of phospho-c-Jun (Ser243) and c-Jun expression, with β-actin as loading control. (B) In vitro kinase assay to test the phosphorylation of c-Jun protein by ULK2 protein. (C-D) Quantification of ULK2 and c-Jun immunofluorescence signals was performed using IPP 6.0 software. E. ULK2 and c-Jun were examined by immunofluorescence. (F) Co-IP analysis indicated an interaction between ULK2 and c-Jun in chemoresistant ovarian cancer organoid. (G) Analysis of protein stability by cycloheximide (CHX) chase assay. Western blot of organoid lysates following treatment with CHX (50 μg/mL) for the indicated durations. (H) c-Jun was immunoprecipitated from chemoresistant ovarian cancer organoids and subsequently probed with an antiubiquitin antibody by Western blot. (I) Analysis of c-Jun mRNA expression by qRT-PCR. (J) c-Jun silencing reduced the cell viability of chemo-resistant ovarian cancer organoid. Organoids were treated with 8 μg/L cisplatin in different time intervals. (K) Assessment of glucose uptake following the knockdown of c-Jun. (L) Analysis of lactate production subsequent to c-Jun silencing. (M) Effect of c-Jun overexpression was verified by qRT-PCR. (N) The overexpression of c-Jun counteracted the decrease in cell viability caused by the upregulation of ULK2 in chemo-resistant ovarian cancer organoid. (O) Glucose uptake assay. (P) Effects of ULK2 overexpression and c-Jun S243A mutation on cell viability in chemoresistant ovarian cancer organoids. Organoids were treated with 8 μg/L cisplatin in different time intervals. Q. ULK2 overexpression suppresses glucose uptake, which is rescued by the c-Jun S243A mutation in chemoresistant ovarian cancer organoids. * p < .05; ** p < .01.
    Figure Legend Snippet: ULK2 modulated c-Jun phosphorylation in ovarian cancer organoids. (A) Immunoblot analysis of phospho-c-Jun (Ser243) and c-Jun expression, with β-actin as loading control. (B) In vitro kinase assay to test the phosphorylation of c-Jun protein by ULK2 protein. (C-D) Quantification of ULK2 and c-Jun immunofluorescence signals was performed using IPP 6.0 software. E. ULK2 and c-Jun were examined by immunofluorescence. (F) Co-IP analysis indicated an interaction between ULK2 and c-Jun in chemoresistant ovarian cancer organoid. (G) Analysis of protein stability by cycloheximide (CHX) chase assay. Western blot of organoid lysates following treatment with CHX (50 μg/mL) for the indicated durations. (H) c-Jun was immunoprecipitated from chemoresistant ovarian cancer organoids and subsequently probed with an antiubiquitin antibody by Western blot. (I) Analysis of c-Jun mRNA expression by qRT-PCR. (J) c-Jun silencing reduced the cell viability of chemo-resistant ovarian cancer organoid. Organoids were treated with 8 μg/L cisplatin in different time intervals. (K) Assessment of glucose uptake following the knockdown of c-Jun. (L) Analysis of lactate production subsequent to c-Jun silencing. (M) Effect of c-Jun overexpression was verified by qRT-PCR. (N) The overexpression of c-Jun counteracted the decrease in cell viability caused by the upregulation of ULK2 in chemo-resistant ovarian cancer organoid. (O) Glucose uptake assay. (P) Effects of ULK2 overexpression and c-Jun S243A mutation on cell viability in chemoresistant ovarian cancer organoids. Organoids were treated with 8 μg/L cisplatin in different time intervals. Q. ULK2 overexpression suppresses glucose uptake, which is rescued by the c-Jun S243A mutation in chemoresistant ovarian cancer organoids. * p < .05; ** p < .01.

    Techniques Used: Phospho-proteomics, Western Blot, Expressing, Control, In Vitro, Kinase Assay, Immunofluorescence, Software, Co-Immunoprecipitation Assay, Immunoprecipitation, Quantitative RT-PCR, Knockdown, Over Expression, Mutagenesis

    ULK2 overexpression potentiated cisplatin sensitivity in ovarian cancer in xenograft models. (A) Images of subcutaneous xenograft tumor models established in nude mice. (B) The graph displayed the tumor growth progression observed in the nude mouse subjects. (C) Evaluation of tumor weights was conducted. ** p < .01. (D) Immunohistochemistry was performed to assess the association of ULK2, c-Jun and its phosphorylation at Ser243 site. (E) Immunofluorescence analysis was executed to confirm the interaction between ULK2 and p-c-Jun (Ser243) within the subcutaneous xenograft tumors. (F) Quantification of p-c-Jun (Ser243) immunofluorescence signal was performed using IPP 6.0 software. (G) Association between ULK2 and c-Jun was tested by immunofluorescence in the mice models. (H) The immunofluorescence intensity of c-Jun was quantified in ovarian cancer organoids using IPP 6.0 software.
    Figure Legend Snippet: ULK2 overexpression potentiated cisplatin sensitivity in ovarian cancer in xenograft models. (A) Images of subcutaneous xenograft tumor models established in nude mice. (B) The graph displayed the tumor growth progression observed in the nude mouse subjects. (C) Evaluation of tumor weights was conducted. ** p < .01. (D) Immunohistochemistry was performed to assess the association of ULK2, c-Jun and its phosphorylation at Ser243 site. (E) Immunofluorescence analysis was executed to confirm the interaction between ULK2 and p-c-Jun (Ser243) within the subcutaneous xenograft tumors. (F) Quantification of p-c-Jun (Ser243) immunofluorescence signal was performed using IPP 6.0 software. (G) Association between ULK2 and c-Jun was tested by immunofluorescence in the mice models. (H) The immunofluorescence intensity of c-Jun was quantified in ovarian cancer organoids using IPP 6.0 software.

    Techniques Used: Over Expression, Immunohistochemistry, Phospho-proteomics, Immunofluorescence, Software

    Related Articles

    Phospho-proteomics:

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: Images were acquired using a Nikon fluorescence microscope.Images were acquired using a Nikon fluorescence microscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: Images were acquired using a Nikon fluorescencemicroscope.Images were acquired using a Nikon fluorescencemicroscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Western Blot:

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: Images were acquired using a Nikon fluorescence microscope.Images were acquired using a Nikon fluorescence microscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: Images were acquired using a Nikon fluorescencemicroscope.Images were acquired using a Nikon fluorescencemicroscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Expressing:

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: Images were acquired using a Nikon fluorescence microscope.Images were acquired using a Nikon fluorescence microscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: Images were acquired using a Nikon fluorescencemicroscope.Images were acquired using a Nikon fluorescencemicroscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Control:

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: Images were acquired using a Nikon fluorescence microscope.Images were acquired using a Nikon fluorescence microscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: Images were acquired using a Nikon fluorescencemicroscope.Images were acquired using a Nikon fluorescencemicroscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    In Vitro:

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: Images were acquired using a Nikon fluorescence microscope.Images were acquired using a Nikon fluorescence microscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: Images were acquired using a Nikon fluorescencemicroscope.Images were acquired using a Nikon fluorescencemicroscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Kinase Assay:

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: Images were acquired using a Nikon fluorescence microscope.Images were acquired using a Nikon fluorescence microscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: Images were acquired using a Nikon fluorescencemicroscope.Images were acquired using a Nikon fluorescencemicroscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Immunofluorescence:

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: Images were acquired using a Nikon fluorescence microscope.Images were acquired using a Nikon fluorescence microscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: Images were acquired using a Nikon fluorescencemicroscope.Images were acquired using a Nikon fluorescencemicroscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Software:

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: Images were acquired using a Nikon fluorescence microscope.Images were acquired using a Nikon fluorescence microscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: Images were acquired using a Nikon fluorescencemicroscope.Images were acquired using a Nikon fluorescencemicroscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Co-Immunoprecipitation Assay:

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: Images were acquired using a Nikon fluorescence microscope.Images were acquired using a Nikon fluorescence microscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: Images were acquired using a Nikon fluorescencemicroscope.Images were acquired using a Nikon fluorescencemicroscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Immunoprecipitation:

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: Images were acquired using a Nikon fluorescence microscope.Images were acquired using a Nikon fluorescence microscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: Images were acquired using a Nikon fluorescencemicroscope.Images were acquired using a Nikon fluorescencemicroscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Quantitative RT-PCR:

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: Images were acquired using a Nikon fluorescence microscope.Images were acquired using a Nikon fluorescence microscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: Images were acquired using a Nikon fluorescencemicroscope.Images were acquired using a Nikon fluorescencemicroscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Knockdown:

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: Images were acquired using a Nikon fluorescence microscope.Images were acquired using a Nikon fluorescence microscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: Images were acquired using a Nikon fluorescencemicroscope.Images were acquired using a Nikon fluorescencemicroscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Over Expression:

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: Images were acquired using a Nikon fluorescence microscope.Images were acquired using a Nikon fluorescence microscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: Images were acquired using a Nikon fluorescencemicroscope.Images were acquired using a Nikon fluorescencemicroscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Mutagenesis:

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: Images were acquired using a Nikon fluorescence microscope.Images were acquired using a Nikon fluorescence microscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: Images were acquired using a Nikon fluorescencemicroscope.Images were acquired using a Nikon fluorescencemicroscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Immunohistochemistry:

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).ULK2 antibody (PA5-22173) was procured from Thermo Fisher Scientific (Waltham, MA, USA).. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).. The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).The secondary antibodies used for immunohistochemistry were all HRP-conjugated goat anti-rabbit immunoglobulins, obtained from Abcam (ab6721, Cambridge, United Kingdom).

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation
    Article Snippet: Images were acquired using a Nikon fluorescence microscope.Images were acquired using a Nikon fluorescence microscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation.
    Article Snippet: Images were acquired using a Nikon fluorescencemicroscope.Images were acquired using a Nikon fluorescencemicroscope.. P-c-Jun (Ser243) antibody was obtained from Absin (abs148022). c-Jun (9165) antibody were obtained from Cell Signaling Technology.



    Similar Products

    94
    Cell Signaling Technology Inc p c jun ser243 antibody
    ULK2 modulated c-Jun phosphorylation in ovarian cancer organoids. (A) Immunoblot analysis of phospho-c-Jun <t>(Ser243)</t> and c-Jun expression, with β-actin as loading control. (B) In vitro kinase assay to test the phosphorylation of c-Jun protein by ULK2 protein. (C-D) Quantification of ULK2 and c-Jun immunofluorescence signals was performed using IPP 6.0 software. E. ULK2 and c-Jun were examined by immunofluorescence. (F) Co-IP analysis indicated an interaction between ULK2 and c-Jun in chemoresistant ovarian cancer organoid. (G) Analysis of protein stability by cycloheximide (CHX) chase assay. Western blot of organoid lysates following treatment with CHX (50 μg/mL) for the indicated durations. (H) c-Jun was immunoprecipitated from chemoresistant ovarian cancer organoids and subsequently probed with an antiubiquitin antibody by Western blot. (I) Analysis of c-Jun mRNA expression by qRT-PCR. (J) c-Jun silencing reduced the cell viability of chemo-resistant ovarian cancer organoid. Organoids were treated with 8 μg/L cisplatin in different time intervals. (K) Assessment of glucose uptake following the knockdown of c-Jun. (L) Analysis of lactate production subsequent to c-Jun silencing. (M) Effect of c-Jun overexpression was verified by qRT-PCR. (N) The overexpression of c-Jun counteracted the decrease in cell viability caused by the upregulation of ULK2 in chemo-resistant ovarian cancer organoid. (O) Glucose uptake assay. (P) Effects of ULK2 overexpression and c-Jun S243A mutation on cell viability in chemoresistant ovarian cancer organoids. Organoids were treated with 8 μg/L cisplatin in different time intervals. Q. ULK2 overexpression suppresses glucose uptake, which is rescued by the c-Jun S243A mutation in chemoresistant ovarian cancer organoids. * p < .05; ** p < .01.
    P C Jun Ser243 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p+c+jun+ser243+antibody/Phospho-c-Jun+(Ser243)+Antibody/pmc12924953-50-0-17
    Average 94 stars, based on 1 article reviews
    p c jun ser243 antibody - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    90
    Affinity Biosciences anti-p–c-jun (ser243) antibody
    ULK2 modulated c-Jun phosphorylation in ovarian cancer organoids. (A) Immunoblot analysis of phospho-c-Jun <t>(Ser243)</t> and c-Jun expression, with β-actin as loading control. (B) In vitro kinase assay to test the phosphorylation of c-Jun protein by ULK2 protein. (C-D) Quantification of ULK2 and c-Jun immunofluorescence signals was performed using IPP 6.0 software. E. ULK2 and c-Jun were examined by immunofluorescence. (F) Co-IP analysis indicated an interaction between ULK2 and c-Jun in chemoresistant ovarian cancer organoid. (G) Analysis of protein stability by cycloheximide (CHX) chase assay. Western blot of organoid lysates following treatment with CHX (50 μg/mL) for the indicated durations. (H) c-Jun was immunoprecipitated from chemoresistant ovarian cancer organoids and subsequently probed with an antiubiquitin antibody by Western blot. (I) Analysis of c-Jun mRNA expression by qRT-PCR. (J) c-Jun silencing reduced the cell viability of chemo-resistant ovarian cancer organoid. Organoids were treated with 8 μg/L cisplatin in different time intervals. (K) Assessment of glucose uptake following the knockdown of c-Jun. (L) Analysis of lactate production subsequent to c-Jun silencing. (M) Effect of c-Jun overexpression was verified by qRT-PCR. (N) The overexpression of c-Jun counteracted the decrease in cell viability caused by the upregulation of ULK2 in chemo-resistant ovarian cancer organoid. (O) Glucose uptake assay. (P) Effects of ULK2 overexpression and c-Jun S243A mutation on cell viability in chemoresistant ovarian cancer organoids. Organoids were treated with 8 μg/L cisplatin in different time intervals. Q. ULK2 overexpression suppresses glucose uptake, which is rescued by the c-Jun S243A mutation in chemoresistant ovarian cancer organoids. * p < .05; ** p < .01.
    Anti P–C Jun (Ser243) Antibody, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p+c+jun+ser243+antibody/phospho+ser243++c+jun++af3090++antibody/10__1007_slash_s13273___021___00119___8-48-10-17
    Average 90 stars, based on 1 article reviews
    anti-p–c-jun (ser243) antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc p cjun
    ULK2 modulated c-Jun phosphorylation in ovarian cancer organoids. (A) Immunoblot analysis of phospho-c-Jun <t>(Ser243)</t> and c-Jun expression, with β-actin as loading control. (B) In vitro kinase assay to test the phosphorylation of c-Jun protein by ULK2 protein. (C-D) Quantification of ULK2 and c-Jun immunofluorescence signals was performed using IPP 6.0 software. E. ULK2 and c-Jun were examined by immunofluorescence. (F) Co-IP analysis indicated an interaction between ULK2 and c-Jun in chemoresistant ovarian cancer organoid. (G) Analysis of protein stability by cycloheximide (CHX) chase assay. Western blot of organoid lysates following treatment with CHX (50 μg/mL) for the indicated durations. (H) c-Jun was immunoprecipitated from chemoresistant ovarian cancer organoids and subsequently probed with an antiubiquitin antibody by Western blot. (I) Analysis of c-Jun mRNA expression by qRT-PCR. (J) c-Jun silencing reduced the cell viability of chemo-resistant ovarian cancer organoid. Organoids were treated with 8 μg/L cisplatin in different time intervals. (K) Assessment of glucose uptake following the knockdown of c-Jun. (L) Analysis of lactate production subsequent to c-Jun silencing. (M) Effect of c-Jun overexpression was verified by qRT-PCR. (N) The overexpression of c-Jun counteracted the decrease in cell viability caused by the upregulation of ULK2 in chemo-resistant ovarian cancer organoid. (O) Glucose uptake assay. (P) Effects of ULK2 overexpression and c-Jun S243A mutation on cell viability in chemoresistant ovarian cancer organoids. Organoids were treated with 8 μg/L cisplatin in different time intervals. Q. ULK2 overexpression suppresses glucose uptake, which is rescued by the c-Jun S243A mutation in chemoresistant ovarian cancer organoids. * p < .05; ** p < .01.
    P Cjun, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p+c+jun+ser243+antibody/Phospho-c-Jun+(Ser243)+Antibody/pmc05358483-226-44-9
    Average 94 stars, based on 1 article reviews
    p cjun - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    Image Search Results


    ULK2 modulated c-Jun phosphorylation in ovarian cancer organoids. (A) Immunoblot analysis of phospho-c-Jun (Ser243) and c-Jun expression, with β-actin as loading control. (B) In vitro kinase assay to test the phosphorylation of c-Jun protein by ULK2 protein. (C-D) Quantification of ULK2 and c-Jun immunofluorescence signals was performed using IPP 6.0 software. E. ULK2 and c-Jun were examined by immunofluorescence. (F) Co-IP analysis indicated an interaction between ULK2 and c-Jun in chemoresistant ovarian cancer organoid. (G) Analysis of protein stability by cycloheximide (CHX) chase assay. Western blot of organoid lysates following treatment with CHX (50 μg/mL) for the indicated durations. (H) c-Jun was immunoprecipitated from chemoresistant ovarian cancer organoids and subsequently probed with an antiubiquitin antibody by Western blot. (I) Analysis of c-Jun mRNA expression by qRT-PCR. (J) c-Jun silencing reduced the cell viability of chemo-resistant ovarian cancer organoid. Organoids were treated with 8 μg/L cisplatin in different time intervals. (K) Assessment of glucose uptake following the knockdown of c-Jun. (L) Analysis of lactate production subsequent to c-Jun silencing. (M) Effect of c-Jun overexpression was verified by qRT-PCR. (N) The overexpression of c-Jun counteracted the decrease in cell viability caused by the upregulation of ULK2 in chemo-resistant ovarian cancer organoid. (O) Glucose uptake assay. (P) Effects of ULK2 overexpression and c-Jun S243A mutation on cell viability in chemoresistant ovarian cancer organoids. Organoids were treated with 8 μg/L cisplatin in different time intervals. Q. ULK2 overexpression suppresses glucose uptake, which is rescued by the c-Jun S243A mutation in chemoresistant ovarian cancer organoids. * p < .05; ** p < .01.

    Journal: Science Progress

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation

    doi: 10.1177/00368504261421695

    Figure Lengend Snippet: ULK2 modulated c-Jun phosphorylation in ovarian cancer organoids. (A) Immunoblot analysis of phospho-c-Jun (Ser243) and c-Jun expression, with β-actin as loading control. (B) In vitro kinase assay to test the phosphorylation of c-Jun protein by ULK2 protein. (C-D) Quantification of ULK2 and c-Jun immunofluorescence signals was performed using IPP 6.0 software. E. ULK2 and c-Jun were examined by immunofluorescence. (F) Co-IP analysis indicated an interaction between ULK2 and c-Jun in chemoresistant ovarian cancer organoid. (G) Analysis of protein stability by cycloheximide (CHX) chase assay. Western blot of organoid lysates following treatment with CHX (50 μg/mL) for the indicated durations. (H) c-Jun was immunoprecipitated from chemoresistant ovarian cancer organoids and subsequently probed with an antiubiquitin antibody by Western blot. (I) Analysis of c-Jun mRNA expression by qRT-PCR. (J) c-Jun silencing reduced the cell viability of chemo-resistant ovarian cancer organoid. Organoids were treated with 8 μg/L cisplatin in different time intervals. (K) Assessment of glucose uptake following the knockdown of c-Jun. (L) Analysis of lactate production subsequent to c-Jun silencing. (M) Effect of c-Jun overexpression was verified by qRT-PCR. (N) The overexpression of c-Jun counteracted the decrease in cell viability caused by the upregulation of ULK2 in chemo-resistant ovarian cancer organoid. (O) Glucose uptake assay. (P) Effects of ULK2 overexpression and c-Jun S243A mutation on cell viability in chemoresistant ovarian cancer organoids. Organoids were treated with 8 μg/L cisplatin in different time intervals. Q. ULK2 overexpression suppresses glucose uptake, which is rescued by the c-Jun S243A mutation in chemoresistant ovarian cancer organoids. * p < .05; ** p < .01.

    Article Snippet: P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).

    Techniques: Phospho-proteomics, Western Blot, Expressing, Control, In Vitro, Kinase Assay, Immunofluorescence, Software, Co-Immunoprecipitation Assay, Immunoprecipitation, Quantitative RT-PCR, Knockdown, Over Expression, Mutagenesis

    ULK2 overexpression potentiated cisplatin sensitivity in ovarian cancer in xenograft models. (A) Images of subcutaneous xenograft tumor models established in nude mice. (B) The graph displayed the tumor growth progression observed in the nude mouse subjects. (C) Evaluation of tumor weights was conducted. ** p < .01. (D) Immunohistochemistry was performed to assess the association of ULK2, c-Jun and its phosphorylation at Ser243 site. (E) Immunofluorescence analysis was executed to confirm the interaction between ULK2 and p-c-Jun (Ser243) within the subcutaneous xenograft tumors. (F) Quantification of p-c-Jun (Ser243) immunofluorescence signal was performed using IPP 6.0 software. (G) Association between ULK2 and c-Jun was tested by immunofluorescence in the mice models. (H) The immunofluorescence intensity of c-Jun was quantified in ovarian cancer organoids using IPP 6.0 software.

    Journal: Science Progress

    Article Title: ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation

    doi: 10.1177/00368504261421695

    Figure Lengend Snippet: ULK2 overexpression potentiated cisplatin sensitivity in ovarian cancer in xenograft models. (A) Images of subcutaneous xenograft tumor models established in nude mice. (B) The graph displayed the tumor growth progression observed in the nude mouse subjects. (C) Evaluation of tumor weights was conducted. ** p < .01. (D) Immunohistochemistry was performed to assess the association of ULK2, c-Jun and its phosphorylation at Ser243 site. (E) Immunofluorescence analysis was executed to confirm the interaction between ULK2 and p-c-Jun (Ser243) within the subcutaneous xenograft tumors. (F) Quantification of p-c-Jun (Ser243) immunofluorescence signal was performed using IPP 6.0 software. (G) Association between ULK2 and c-Jun was tested by immunofluorescence in the mice models. (H) The immunofluorescence intensity of c-Jun was quantified in ovarian cancer organoids using IPP 6.0 software.

    Article Snippet: P-c-Jun (Ser243) antibody was obtained from Absin (abs148022, Shanghai, China), and c-Jun (9165) antibody was sourced from Cell Signaling Technology (Boston, MA, USA).

    Techniques: Over Expression, Immunohistochemistry, Phospho-proteomics, Immunofluorescence, Software